In a filing, Terns Pharmaceuticals Inc revealed its Chief Medical Officer Kuriakose Emil unloaded Company’s shares for reported $7407.0 on Oct 01 ’25. In the deal valued at $7.85 per share,944 shares were sold. As a result of this transaction, Kuriakose Emil now holds 51,520 shares worth roughly $0.72 million.
Then, Kuriakose Emil sold 853 shares, generating $3,640 in total proceeds. Upon selling the shares at $4.27, the Chief Medical Officer now owns 52,464 shares.
Before that, Gengos Andrew bought 10,000 shares. Terns Pharmaceuticals Inc shares valued at $39,283 were divested by the Chief Financial Officer at a price of $3.93 per share. As a result of the transaction, Gengos Andrew now holds 25,000 shares, worth roughly $0.35 million.
William Blair upgraded its Terns Pharmaceuticals Inc [TERN] rating to an Outperform from a a Mkt perform in a research note published recently. A number of analysts have revised their coverage, including Truist’s analysts, who began to cover the stock in mid October with a ‘”a Buy”‘ rating. Barclays began covering TERN with “an Overweight” recommendation on September 17, 2025.
Price Performance Review of TERN
On Monday, Terns Pharmaceuticals Inc [NASDAQ:TERN] saw its stock jump 69.85% to $14.03. Over the last five days, the stock has gained 74.07%. Terns Pharmaceuticals Inc shares have risen nearly 103.63% since the year began. Nevertheless, the stocks have risen 153.25% over the past one year. While a 52-week high of $9.03 was reached on 11/03/25, a 52-week low of $1.87 was recorded on 04/07/25.
Levels Of Support And Resistance For TERN Stock
The 24-hour chart illustrates a support level at 12.44, which if violated will result in even more drops to 10.86. On the upside, there is a resistance level at 15.94. A further resistance level may holdings at 17.86.
How much short interest is there in Terns Pharmaceuticals Inc?
A steep rise in short interest was recorded in Terns Pharmaceuticals Inc stocks on 2025-10-15, growing by 2.05 million shares to a total of 10.36 million shares. Yahoo Finance data shows the prior-month short interest on 2025-09-15 was 8.31 million shares. There was a rise of 19.82%, which implies that there is a positive sentiment for the stock.
The most recent change occurred on February 28, 2025 when William Blair began covering the stock and recommended ‘”a Mkt perform”‘ rating.
